IMPACT OF GONADOTROPIN-RELEASING HORMONE AGONIST POST-OPERATIVE TREATMENT ON OVARIAN RESERVE CHANGES AFTER LAPAROSCOPIC SURGERY OF OVARIAN ENDOMETRIOMA.

被引：0
|
作者：
Shim, Yoo Jin [1 ]
Lee, Jung Ryeol [1 ]
机构：
[1] Seoul Natl Univ, Bundang Hosp, Seongnam, South Korea
来源：
FERTILITY AND STERILITY | 2019年 / 112卷 / 03期
关键词：
D O I：
10.1016/j.fertnstert.2019.07.929
中图分类号：
R71 [妇产科学];
学科分类号：
100211 ;
摘要：
P-533
引用
收藏
页码：E321 / E321
页数：1
相关论文
共 50 条
  • [31] Ovarian protection and safety of gonadotropin-releasing hormone agonist after cervical cancer surgery: systematic review and meta-analysis
    Yuan, Jialing
    Lai, Yi
    Li, Tao
    [J]. ANNALS OF TRANSLATIONAL MEDICINE, 2022, 10 (07)
  • [32] Gonadotropine-releasing hormone agonist treatment reduced expression of interleukin-8 in stromal cells derived from ovarian endometrioma.
    Sakamoto, Y
    Harada, T
    Iwabe, T
    Terakawa, N
    [J]. FERTILITY AND STERILITY, 2002, 78 (03) : S203 - S204
  • [33] Effect of gonadotropin-releasing hormone analog on ovarian reserve in children with central precocious puberty
    Tao, Yuehong
    Si, Caiyun
    Li, Haiyan
    Han, Jing
    Hou, Huidan
    Yang, Mei
    [J]. ANNALS OF PALLIATIVE MEDICINE, 2020, 9 (01) : 53 - 62
  • [34] Luteolysis induced by a gonadotropin-releasing hormone agonist is the key to prevention of ovarian hyperstimulation syndrome
    Kol, S
    [J]. FERTILITY AND STERILITY, 2004, 81 (01) : 1 - 5
  • [35] Effect of ovarian suppression with gonadotropin-releasing hormone agonist on glucose disposal and insulin secretion
    Toth, Michael J.
    Cooper, Brian C.
    Pratley, Richard E.
    Mari, Andrea
    Matthews, Dwight E.
    Casson, Peter R.
    [J]. AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM, 2008, 294 (06): : E1035 - E1045
  • [36] OVARIAN HYPERSTIMULATION FOR IN VITRO FERTILIZATION PRECEDED BY PROLONGED ADMINISTRATION OF A GONADOTROPIN-RELEASING HORMONE AGONIST
    Tanbo, Tom
    Dale, Per Olav
    Abyholm, Thomas
    [J]. ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA, 1990, 69 (04) : 333 - 337
  • [37] Prevention of paclitaxel and cisplatin induced ovarian damage in rats by a gonadotropin-releasing hormone agonist
    Ozcelik, Bulent
    Turkyilmaz, Cagdas
    Ozgun, Mahmut Tuncay
    Serin, Ibrahim Serdar
    Batukan, Cem
    Ozdamar, Saim
    Ozturk, Ahmet
    [J]. FERTILITY AND STERILITY, 2010, 93 (05) : 1609 - 1614
  • [38] Effect of gonadotropin-releasing hormone agonist on ES-2 ovarian cancer cells
    Tsui, Kuan-Hao
    Lee, Wen-Ling
    Seow, Kok-Min
    Yang, Lin-Wei
    Wang, Shih-Yi
    Wang, Peng-Hui
    Chang, Chi-Lun
    Yen, Ming-Shyen
    Cheng, Jiin-Tsuey
    Chen, Chih-Ping
    [J]. TAIWANESE JOURNAL OF OBSTETRICS & GYNECOLOGY, 2014, 53 (01): : 35 - 42
  • [39] RECOVERY OF HORMONE-SECRETION AFTER CHRONIC GONADOTROPIN-RELEASING HORMONE AGONIST ADMINISTRATION IN WOMEN WITH POLYCYSTIC OVARIAN DISEASE
    DEZIEGLER, D
    STEINGOLD, K
    CEDARS, M
    LU, JKH
    MELDRUM, DR
    JUDD, HL
    CHANG, RJ
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1989, 68 (06): : 1111 - 1117
  • [40] Prediction of ovarian function recovery after ovarian protection with gonadotropin-releasing hormone agonist during chemotherapy in young breast cancer patients
    Lee, D. Y.
    Mok, C. W.
    Choi, D.
    [J]. HUMAN REPRODUCTION, 2017, 32 : 373 - 373
12345